Search Results
Site Search
PDL1 Testing for Lung Cancer [A Test in Focus] - Insights
Audio Interview Testing When to Order Specimen Performance Immunotherapies have recently emerged as a therapeutic option for patients with non-small-cell
Chromium and Cobalt Testing [Test in Focus] - Insights
Chromium and cobalt blood tests are used to monitor exposure to these elements. Both of these elements are naturally occurring and widely distributed in the environment. Previously, serum samples were collected and used to monitor patients...
Delta Health: Confronting a global pandemic in rural Colorado - Insights
Delta Health leveraged their relationship with Mayo Clinic Laboratories to support patient in rural Colorado during the COVID-19 pandemic. Delta Health and Mayo Clinic Laboratories have collaborated for over 17 years to perform complex and...
Request Information - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
Lyme Disease, Part 2: Borrelia mayonii-A New Cause of Lyme Disease in Upper Midwest - Insights
In this “Hot Topic,” Bobbi Pritt, M.D., discusses how Lyme disease is the most common vector-borne illness in the United States and Europe and caused primarily by Borrelia burgdorferi in the United States, while B burgdorferi, B afzelii,...
Mayo Clinic Labs @Work: Deb Wells - Insights
Deb Wells is the director of Quality Management Services at Mayo Clinic Laboratories. A science lover from a young age, Deb has long worked in medical laboratory science and is passionate about being an advocate for lab safety and quality.
MCL @Work: Samantha Aldrich - Insights
Before joining Mayo Clinic, Samantha Aldrich worked for a multisite hospital system in Michigan for 10 years. Now, as a regional service representative for Mayo Clinic Laboratories, she serves as a client advocate and works to help send out...
Mayo Clinic Labs @Work: Clyde Christian III - Insights
Following a connection on LinkedIn, Clyde Christian found himself drawn to Mayo Clinic and joined the Hospital Sales division of Mayo Clinic Laboratories in late May 2022. As a hospital account executive for the U.S. Great Lakes region,...
New Tests Launched in February - Insights
In February 2019, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
CPT codes and LOINC update: April 2022 - Insights
This list includes updates posted to mayocliniclabs.com during the month of April.
Gastrointestinal Stromal Tumor Panel [Test in Focus] - Insights
Rondell P. Graham, M.B.B.S., gives an overview of this test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon previous testing approaches, what clinical action can...
Enhanced detection of genetic mutation to optimize leukemia treatment - Insights
Rong He, M.D., describes how Mayo Clinic Laboratories’ NPM1Q assay detects all known forms of a genetic mutation found in about 30% of people with acute myeloid leukemia, or AML. Identifying the NPM1 mutation is critical for clinical...
Melanoma panel provides more tumor information - Insights
In this test specific episode of the "Answers From the Lab" podcast, Ruifeng (Ray) Guo, M.D., Ph.D., explains how Mayo Clinic Laboratories' comprehensive melanoma panel better informs prognosis and treatment.
Comprehensive panel boosts GIST diagnosis sensitivity - Insights
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new assay for gastrointestinal stromal tumors, or GIST. The panel covers multiple mutations, to better inform diagnosis and treatment options.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) - Insights
Divyanshu (Div) Dubey, M.B.B.S., describes Mayo Clinic Laboratories' new diagnostic test for CIDP, or chronic inflammatory demyelinating polyneuropathy. The new test detects two antibodies — NF155 and CNTN1 — to enhance diagnosis and guide...
Mayo Clinic Laboratory and pathology research roundup: February 15 - Insights
This week's Research Roundup features: Activity of a hypochlorous acid-producing electrochemical bandage as assessed with a porcine explant biofilm model.
A Sysmex Game of Telephone - Insights
Rachel Olk, a student in the Mayo Clinic Medical Laboratory Science class of 2018, talks about her experience with the Sysmex Hematology Analyzer during a game of "Telephone" in the laboratory.
Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder that typically presents with progressive multisystem involvement in early childhood. This condition results from the deficiency of the enzyme, alpha-L-iduronidase (IDUA), which...
Nonalcoholic Steatohepatitis (NASH)-FibroTest* [Test in Focus] - Insights
Nikola Baumann, Ph.D., gives an overview of the new NASH-FibroTest available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical...
Updated testing algorithms for plasma cell proliferative disorders [Test in Focus] - Insights
Xinjie Xu, Ph.D., co-director of Mayo's Genetics and Genomics Laboratory, explains Mayo Clinic Laboratories' updated approach to testing for risk stratification of patients newly diagnosed with plasma cell proliferative disorders, such as...
Severe storms affecting FedEx hub in Memphis, TN - Insights
Due to severe weather affecting the FedEx hub in Memphis, Tennessee, delays are anticipated. The Mayo Clinic Laboratories’ Global Logistics team will be diverting work to other commercial shipping options.
MAG Antibody Testing [Test in Focus] - Insights
John Mills, Ph.D., explains Mayo Clinic Laboratories’ approach to MAG antibody testing. The ELISA-based assay uses higher reference ranges and human MAG antigen to detect MAG antibodies, which are associated with a rare, hard-to-treat...
Research Roundup Archives - Page 2 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Archives - Page 2 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Antimicrobial susceptibility testing determines whether these bacteria are susceptible or resistant to a particular antibiotic. Bacteria are added onto plates of solid agar, where each plate has a different and increasing concentration of...
Weather Preparedness: Hey, How's That Weather? - Insights
Weather always seems to be at the forefront of people's minds and discussions—especially in Minnesota. We are always commenting on needing more rain, that it’s too cold, or that a blizzard is on its way. Weather, however, is no trivial...
MCL @Work: Adam Stewart - Insights
In spring of 2022, Adam Stewart joined Mayo Clinic’s Blood Donor Program as a marketing and recruitment coordinator. He enjoys and finds great purpose in his work because he loves to see members of his local community donate blood and help...
Chromium and Cobalt - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate...
Laboratory Utilization Management: Tick-Borne Disease Testing - Insights
In this month's "Hot Topic," Elitza Theel, Ph.D., will be discussing laboratory utilization management, specifically for diagnostic testing for tick-borne diseases.
MCL - TREC Assay Patient Information - MC1235-119
MCL - TREC Assay Patient Information
Forms - Mayo Clinic Laboratories
Share Print Web: mayocliniclabs.com...
CPT Code Updates - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
Gratitude for your collaboration in 2024 - Insights
Mayo Clinic Laboratories is grateful for your collaboration in 2024.
Some Interesting Applications in the Medical Laboratory Science Program - Insights
Elizabeth Atneosen, a student in the Mayo Clinic Medical Laboratory Science program, discusses interesting applications she has learned thus far in the program.
Once again, the Cytogenetic, Molecular Genetic, and Biochemical Genetic communities participated in the Association of Genetic Technologists Annual Meeting. This year, the Mayo Clinic Cytogenetics Laboratory was well-represented at the...
Overcoming Fear of Public Speaking with "The Art of Laughter" - Insights
Nhien Chau, Clinical Laboratory Technologist in the Biochemical Genetics Laboratory at Mayo Clinic, decided to face his fear of public speaking by joining the Rochester Chamber Toastmasters group.
Neurofascin 155 IgG4 Antibody Test [Test in Focus] - Insights
John Mills, Ph.D., explains Mayo Clinic Laboratories' new neurofascin 155 (NF155) IgG4 antibody test, which is the first commercially available test in the U.S. to use flow cytometry to detect for NF155 antibodies and confirm diagnosis of...
Clinical and forensic toxicology - Insights
Clinical, forensic, and emergency toxicology testing at Mayo Clinic Laboratories, which aligns with evidence-based clinical laboratory guidelines, uses advanced and emerging technologies and is performed on urine, serum, and meconium...
Disaccharidase Activity Panel [Test in Focus] - Insights
Pua Hopson, D.O., discusses Mayo Clinic Labs’ new disaccharidase activity panel, which measures levels of five digestive enzymes to identify deficiencies that cause carbohydrate maldigestion and can lead to chronic conditions like celiac...
Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D. - Insights
Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost...
Updated assay guides diagnosis of autoimmune liver disease: Anne Tebo, Ph.D. - Insights
Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' updated ALDG2 assay helps with the evaluation of patients with suspected autoimmune liver disease. The panel also helps with the evaluation of liver disease of unknown etiology.
Patients with elevated LDL or "bad" cholesterol face even greater risk if their levels of small dense LDL cholesterol are also high. Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D., explain how Mayo Clinic Laboratories' sdLDL-c assay...
length - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
Shipping - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
Week in Review: January 13 - Insights
Topic highlights include: With attention to mpox fading, health officials fear infections will go undetected and unreported, As COVID surges in China, US begins testing more travelers, FDA approves Alzheimer's drug that appears to modestly...
Mayo Medical Laboratories Rebrands Its Name as Mayo Clinic Laboratories - Insights
Mayo Medical Laboratories, the global reference laboratory of Mayo Clinic, has changed its name to Mayo Clinic Laboratories.
Message to Our Health Care Partners During Unsettling Times - Insights
As we enter a second week of protest and unrest throughout the nation sparked by the deaths of George Floyd and Ahmaud Arbery, we want to recognize the heartache and pain felt because of these events. Added to the uncertainty with...
Saying Goodbye to the MLS Program - Insights
Ali Addesso, a student in Mayo Clinic’s Medical Laboratory Science (MLS) class of 2017, says goodbye to the MLS Program with a heartfelt "thank you" to her peers and teachers.
William Morice II, M.D., Ph.D., discusses COVID-19 testing in The Wall Street Journal - Insights
Dr. Morice, president of Mayo Clinic Laboratories, weighs in on the role of testing and addresses how quickly a COVID-19 infection can be detected.
New Tests Launched in February - Insights
In February 2017, Mayo Medical Laboratories announced nine brand new tests along with numerous reference-value changes, obsolete tests, and algorithm changes.